Treatment of acute ischemic stroke: From fibrinolysis to neurointervention

7Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

Abstract

Thrombolytic therapy with intravenous recombinant tissue plasminogen activator is well established as a beneficial treatment for patients presenting with acute ischemic stroke (AIS). The odds of a favorable clinical outcome (living independently) increase as the time between stroke onset and treatment with IV thrombolysis decreases. However, many patients present with a large clot burden that seldom responds to systemic fibrinolysis. Alternative options include new and emerging endovascular therapies that have recently proven effectiveness at restoring cerebral blood flow to the ischemic brain parenchyma. This review article will briefly outline some of the key evidence for intravenous thrombolysis as well as endovascular therapy for AIS.

Cite

CITATION STYLE

APA

Jacquin, G. J., & Van Adel, B. A. (2015, June 1). Treatment of acute ischemic stroke: From fibrinolysis to neurointervention. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.12971

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free